2017Yemeni Journal For Medical SciencesOpen access

Fighting fake medicines: Quality evaluation of seven brands of Albendazole tablets in Yemeni Market

Gamil Othman

Open full text 8 citations

Abstract

Objective: To assess certain quality control parameters for seven brands of albendazole tablets obtained from different retail pharmacies. Methods: The physicochemical properties and active ingredientsofseven randomly selectedbrands of albendazole tablets were assessed weight uniformity, hardness, friability, disintegration and dissolution Results: All seven albendazole brands met the British Pharmacopeia (BP) quality control standards of weight uniformity, friability and the active ingredient content. Five brands met the BP disintegration criterion,whereas only two brands complied with the BP quality control parameters of the dissolution specifications. Conclusions: Out of the seven brands of albendazole (400 mg) tablets, only two fulfillthe BP quality control standards and show physicochemicalquivalence. This emphasizes the need for regular assessment of marketed drugs to assure equivalenceof these drugs to their innovators.

About this research paper

What this paper is about

Objective: To assess certain quality control parameters for seven brands of albendazole tablets obtained from different retail pharmacies. Methods: The physicochemical properties and active ingredientsofseven randomly selectedbrands of albendazole tablets were assessed weight uniformity, hardness, friability, disintegration and dissolution Results: All seven albendazole brands met the British Pharmacopeia (BP) quality control standards of weight uniformity, friability and the active ingredient content. Five brands met the BP disintegration criterion,whereas only two brands complied with the BP quality control parameters of the dissolution specifications. Conclusions: Out of the seven brands of albendazole (400 mg) tablets, only two fulfillthe BP quality control standards and show physicochemicalquivalence. This emphasizes the need for regular assessment of marketed drugs to assure equivalenceof these drugs to their innovators.

Why it matters

OpenAlex reports 8 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective: To assess certain quality control parameters for seven brands of albendazole tablets obtained from different retail pharmacies. Methods: The physicochemical properties and active ingredientsofseven randomly selectedbrands of albendazole tablets were assessed weight uniformity, hardness, friability, disintegration and dissolution Results: All seven albendazole brands met the British Pharmacopeia (BP) quality control standards of weight uniformity, friability and the active ingredient content. Five brands met the BP disintegration criterion,whereas only two brands complied with the BP quality control parameters of the dissolution specifications. Conclusions: Out of the seven brands of albendazole (400 mg) tablets, only two fulfillthe BP quality control standards and show physicochemicalquivalence. This emphasizes the need for regular assessment of marketed drugs to assure equivalenceof these drugs to their innovators.

Key concepts: Albendazole, Business, Traditional medicine, Quality (philosophy), Advertising, Medicine, Surgery, Epistemology

Related papers

Back to paper searchBrowse research topicsOriginal source
Fighting fake medicines: Quality evaluation of seven brands of Albendazole tablets in Yemeni Market — Research Paper | ScholarLens